GLP-1 Therapies: How They Are Reshaping Aesthetic Dermatology and Skincare
In recent years, GLP-1 receptor agonists (GLP-1 RAs) have shifted from being primarily medical treatments for diabetes and obesity to becoming a significant driver of change in aesthetic medicine and dermatology. These therapies, which include well-known medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are helping millions of people









